Pregabalin Capsule
Product Images NDC 76420-121

Product Visual Gallery

This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 76420-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pregabalin-100mg-1000-jpg (Pregabalin 100mg)

This is a set of label descriptions for different presentations of Pregabalin Capsules 100mg from Enovachem, a pharmaceutical company. The text includes the National Drug Code (NDC) and other details such as package quantity, Drug Status, and source number.*

FDA Label Image

Pregabalin-150mg-1000-jpg (Pregabalin 150mg)

FDA Label Image

Pregabalin-200mg-1000-jpg (Pregabalin 200mg)

Description: This text contains information about Pregabalin Capsule 200mg with NDC code 76420-122-90. The capsule is orange opaque and has LA#S written on it. The text also mentions the manufacturer, Rising Pharmaceuticals Inc., and the product's storage instructions. There is also information about other variants of the capsule with different NDC codes, quantities, and batch numbers.*

FDA Label Image

Pregabalin-225mg-1000-jpg (Pregabalin 225mg)

FDA Label Image

Pregabalin-25mg-1000-jpg (Pregabalin 25mg)

FDA Label Image

Pregabalin-300mg-1000-jpg (Pregabalin 300mg)

This is a list of Pregabalin Capsules with varying quantities and National Drug Codes (NDC) including details on the manufacturers and lots. There is not enough information to provide a more specific description.*

FDA Label Image

Pregabalin-50mg-1000-jpg (Pregabalin 50mg)

This appears to be a list of different versions of Pregabalin Capsules in 50mg dosages, including their NDC codes and some cautionary advice.*

FDA Label Image

Pregabalin-75mg-1000-jpg (Pregabalin 75mg)

FDA Label Image

Pregabalinchemistrystructure (Pregabalin Chem Structure)

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

FDA Label Image

Pregabalinfig1 (Pregabalin Fig 01)

FDA Label Image

Pregabalinfig2 (Pregabalin Fig 02)

The text shows a chart indicating the percent of patients improved after taking Pregabalin 160 mg for 3 days. The chart also shows the percent improvement in pain from baseline, with values ranging from 2 to 100. There appears to be some additional text, but it is unreadable due to errors.*

FDA Label Image

Pregabalinfig3 (Pregabalin Fig 03)

This appears to be a table showing various medications and their recommended dosages, as well as the percentage of patients who experienced pain improvement while taking them. However, the text is not fully readable and some parts are unclear, so a full and accurate description cannot be provided.*

FDA Label Image

Pregabalinfig4 (Pregabalin Fig 04)

FDA Label Image

Pregabalinfig5 (Pregabalin Fig 05)

This appears to be a partially readable clinical trial report evaluating the effects of Fregabalin and Pregataiin on pain relief in patients. The dosage and frequency of administration for each drug are given along with a placebo group. The "Percent Improvement in Pain from Baseline" is also provided, but it is difficult to ascertain the validity of the results due to the unreadable characters and incomplete data.*

FDA Label Image

Pregabalinfig6 (Pregabalin Fig 06)

FDA Label Image

Pregabalinfig7 (Pregabalin Fig 07)

FDA Label Image

Pregabalinfig8 (Pregabalin Fig 08)

This text appears to be a chart showing the different doses of Pregabalin and their effectiveness in improving pain. The chart displays the results in percentages, but the labels and units for the axes are not available.*

FDA Label Image

Pregabalinfig9 (Pregabalin Fig 09)

This text contains a table displaying percentages of subjects without LTR based on the use of Pregabalin and Placebo medication, along with a timeline of 12 days. It is not possible to determine the context or purpose of this information with only the given text.*

FDA Label Image

Pregabalinfig10 (Pregabalin Fig 10)

FDA Label Image

Pregabalinfig11 (Pregabalin Fig 11)

The text shows the percentage of subjects who improved after taking Pregabalin compared to Placebo after 16 weeks. The percentage of improvement ranges from 100 to 280 percent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.